Epirubicin, folinic acid, fluorouracil, and etoposide in the treatment of advanced gastric cancer: phase II study of the Southern Italy Oncology Group (GOIM).

G Colucci; F Giuliani; V Gebbia; A Testa; N Borsellino; G Lelli; S Fortunato; M Lopez; E Maiello; N Gebbia

doi:10.1097/00000421-199906000-00010

Epirubicin, folinic acid, fluorouracil, and etoposide in the treatment of advanced gastric cancer: phase II study of the Southern Italy Oncology Group (GOIM).

Identifier:nobleid.org/w1/20260515/E1A68898

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/E1A68898.svg?ark=w1%2F20260515%2FE1A68898)](https://nobleid.org/work/w1/20260515/E1A68898)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Epirubicin, folinic acid, fluorouracil, and etoposide in the treatment of advanced gastric cancer: phase II study of the Southern Italy Oncology Group (GOIM).

Identifier:nobleid.org/w1/20260515/E1A68898

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/E1A68898.svg?ark=w1%2F20260515%2FE1A68898)](https://nobleid.org/work/w1/20260515/E1A68898)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work